InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Jindal Vineet R., Chief Financial Officer. Director active across 1 company, notably Reneo Pharmaceuticals, Inc.. Aggregated, 4 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €63k. Activity tracked since 25 August 2021. The latest transaction was filed on 10 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
30,000 shares0Common StockSEC:0001209191-21-069448:0
30,000 shares0Common StockSEC:0001209191-21-069448
5,000 shares@ US$7.4353100.0% of flowCommon StockSEC:0001209191-21-053523
Ideal exit: 22 May 2022 (T+270)
5,000 shares@ US$7.435350.0% of flowCommon StockSEC:0001209191-21-053523:0
Ideal exit: 22 May 2022 (T+270)
4 of 4 declarations
About Jindal Vineet R.
Vineet R. Jindal is the Chief Financial Officer of Reneo Pharmaceuticals, Inc. He oversees the financial operations and funding strategy of the company.
